Discontinuation report NOVASEN
Report ID | 63964 |
Drug Identification Number | 00229296 |
Brand name | NOVASEN |
Common or Proper name | ACETYLSALICYLIC ACID |
Company Name | TEVA CANADA LIMITED |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | ACETYLSALICYLIC ACID |
Strength(s) | 650MG |
Dosage form(s) | TABLET (DELAYED-RELEASE) |
Route of administration | ORAL |
Packaging size | 100 |
ATC code | N02BA |
ATC description | OTHER ANALGESICS AND ANTIPYRETICS |
Reason for discontinuation | Business reasons |
Anticipated discontinuation date | |
Actual discontinuation date | 2018-06-30 |
Remaining supply date | 2018-07-30 |
Discontinuation status | Discontinued |
Discontinuation decision reversal | No |
Information on remaining supply | |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 30 NOVOPHARM COURT TORONTO, ONTARIO CANADA M1B 2K9 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v2 | 2018-10-12 | French | Compare |
v1 | 2018-10-12 | English | Compare |
Showing 1 to 2 of 2